Skip to main content

Par Drugs & Chemicals Ltd

NSE: PAR

Par Drugs & Chemicals Ltd (PAR) is a Diversified company listed on NSE: PAR. With a market cap of ₹102 Cr and ROCE of 16.5%, ROE of 12.4%, it operates in the Indian Diversified sector.

83.2
52W: ₹78 — ₹122
PE 7.83 · Book ₹91 · -9% vs book
Market Cap₹102 Cr
Stock P/E7.83Price to Earnings
ROCE16.5%Return on Capital
ROE12.4%Return on Equity
Div. Yield0%Face Value ₹10

Strengths

  • +Company is almost debt free.
  • +Stock is trading at 0.92 times its book value

Weaknesses

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 11.3% over past five years.

Shareholding Pattern

Promoters73.41%
FIIs0%
DIIs0%
Public26.59%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters74.21%73.37%0.873.37%73.37%73.37%73.37%73.41%0.073.41%
FIIs0.32%0.09%0.20%0.10%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%
Public25.47%26.54%1.126.63%0.126.63%26.63%26.63%26.59%0.026.59%

Financial Statements

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales2422.8222.6134.6621.3822.3326.0528.6629.3419.61
Expenses18.7716.7218.3723.2519.9519.922.4922.623.2918.17
Operating Profit5.236.14.2411.411.432.433.566.066.051.44
OPM %21.79%26.73%18.75%32.92%6.69%10.88%13.67%21.14%20.62%7.34%
Net Profit3.423.722.538.60.581.653.334.134.80.85
EPS ₹2.783.022.066.990.471.342.713.363.90.69

AI Insights

Revenue Trend

Mar 2026 revenue at ₹104Cr, up 3% YoY. OPM at 17%.

Debt Position

Borrowings at ₹0Cr. Debt-to-equity ratio: 0.00x. Healthy balance sheet.

Capex Cycle

CWIP at ₹1Cr (3% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 0% (+0.00pp change). FIIs: 0% (+0.00pp change). Promoters hold 73.41%.

Margin & Efficiency

ROCE improving from 10% (Mar 2015) to 17% (Mar 2026). Working capital days: 31.

Valuation

PE 7.83x with 16.5% ROCE. Price is -9% above book value of ₹91. Dividend yield: 0%.

Recent Announcements